EC 313

• Description :

  EC 313 is a novel selective progesterone receptor modulator. EC 313 can dose dependently reduce the weight of fibroids. EC 313 can reduce the expression of ER and PR. EC 313 can be used for the study of uterine fibroids[1].

• UNSPSC :

  12352005

• Target :

  Estrogen Receptor/ERR; Progesterone Receptor

• Related Pathways :

  Vitamin D Related/Nuclear Receptor

• Field of Research :

  Cancer; Endocrinology

• Smiles :

  C[C@@]12[C@@]3(CC[C@@]1([H])[C@@]4([H])C([C@@H](C5=CC=C(C6=COC=C6)C=C5)C2)=C7C(CC4)=CC(CC7)=O)/C(CCO3)=C(F)/F

• Molecular Formula :

  C32H32F2O3

• Molecular Weight :

  502.59

• References & Citations :

  [1]Nair HB, et al. EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fibroids in a human uterine fibroid tissue xenograft model. Sci Rep. 2019 Nov 21;9 (1) :17279.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [1249398-29-5]